Education
About Us
Working with TipRanks
Follow Us
Enzo Biochem (ENZB)
OTHER OTC:ENZB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 31.91M | $ 31.06M | $ 107.07M | $ 117.73M | $ 76.02M |
| Gross Profit | $ 14.63M | $ 11.57M | $ 41.97M | $ 53.58M | $ 23.77M |
| Operating Income | $ -9.82M | $ -24.74M | $ -15.51M | $ 9.88M | $ -23.64M |
| EBITDA | $ -8.35M | $ -20.94M | $ -15.01M | $ 3.35M | $ -27.59M |
| Net Income | $ -26.08M | $ 20.29M | $ -22.58M | $ 3.42M | $ -33.89M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 52.37M | $ 82.37M | $ 21.60M | $ 43.50M | $ 47.87M |
| Total Assets | $ 85.76M | $ 121.88M | $ 95.86M | $ 113.69M | $ 112.54M |
| Total Debt | $ 3.51M | $ 7.00M | $ 20.59M | $ 22.68M | $ 32.79M |
| Net Debt | $ -48.86M | $ -75.38M | $ -1.02M | $ 9.15M | $ -15.07M |
| Total Liabilities | $ 29.65M | $ 43.42M | $ 41.40M | $ 45.10M | $ 54.16M |
| Stockholders' Equity | $ 56.11M | $ 78.46M | $ 54.46M | $ 68.59M | $ 58.38M |
| Cash Flow | |||||
| Free Cash Flow | $ -26.80M | $ -39.74M | $ -20.06M | $ -4.05M | $ -19.35M |
| Operating Cash Flow | $ -26.26M | $ -36.98M | $ -16.59M | $ 387.00K | $ -17.18M |
| Investing Cash Flow | $ -545.00K | $ 98.98M | $ 25.22M | $ -34.50M | $ -2.17M |
| Financing Cash Flow | $ -4.19M | $ -1.13M | $ -241.00K | $ -242.00K | $ 7.00M |